237 related articles for article (PubMed ID: 559690)
41. [Use of bromocriptine to induce ovulation in the galactorrhea-amenorrhea syndrome [].
Hernández Ayup S; Muñoz M; González R; Galache P; Guitrón A; Pancardo RM; Forsbach G
Rev Invest Clin; 1982; 34(2):121-3. PubMed ID: 7123023
[No Abstract] [Full Text] [Related]
42. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
Boyd AE; Reighlin S
N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
[No Abstract] [Full Text] [Related]
43. [Treatment of amenorrhea-galactorrhea with bromo-ergocryptine. Apropos of 12 cases].
Hartemann P; Leclere J; Groussin M; Valdenaire JC; Maureira JJ; Belleville F; Nabet P
J Gynecol Obstet Biol Reprod (Paris); 1977 Jun; 6(4):537-46. PubMed ID: 915214
[TBL] [Abstract][Full Text] [Related]
44. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
[TBL] [Abstract][Full Text] [Related]
45. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
Seki K; Seki M; Okumura T
Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
[TBL] [Abstract][Full Text] [Related]
46. Bromocriptine in the treatment of hyperolactinemic amenorrhea.
Badano AR; Miechi HR; Mirkin A; Arcángeli OA; Aparicio NJ; Rodríguez A; Oliva A; Turner D; Figueroa Casas PR
Fertil Steril; 1979 Feb; 31(2):124-9. PubMed ID: 570131
[TBL] [Abstract][Full Text] [Related]
47. The treatment with 2-brom-alfa ergocriptine in the syndrome amenorrhea-galactorrhea.
Sirbu P; Cioltei A; Simionescu L; Dumbravescu A; Sedan E; Titiriga L; Mîtulescu V
Acta Eur Fertil; 1979 Dec; 10(4):177. PubMed ID: 552769
[TBL] [Abstract][Full Text] [Related]
48. [Intermittent administration of bromocriptine in the treatment of amenorrhea-galactorrhea syndrome].
Hartemann P; Leclere J; Groussin M; Mizrahi R
Nouv Presse Med; 1977 Oct; 6(34):3111. PubMed ID: 562510
[No Abstract] [Full Text] [Related]
49. [Evolution of 15 pregnancies induced with bromocriptine therapy in patients with amenorrhea-galactorrhea].
Campagnoli C; Belforte L; Bruno M; Fessia L; Pinna N; Massara F
Minerva Ginecol; 1980 May; 32(5):400-4. PubMed ID: 7393487
[No Abstract] [Full Text] [Related]
50. Normal pregnancies after treatment of hyperprolactinemia with bromoergocryptine, despite suspected pituitary tumors.
Mornex R; Orgiazzi J; Hugues B; Gagnaire JC; Claustrat B
J Clin Endocrinol Metab; 1978 Aug; 47(2):290-5. PubMed ID: 400717
[TBL] [Abstract][Full Text] [Related]
51. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
Schellekens LA; Roland R; Lequin RM
Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
[No Abstract] [Full Text] [Related]
52. Hyperprolactinaemic amenorrhoea in Hong Kong.
Tang LC; Sung ML; Ma HK
Aust N Z J Obstet Gynaecol; 1983 Aug; 23(3):165-9. PubMed ID: 6580885
[TBL] [Abstract][Full Text] [Related]
53. [Remote results of treatment of galactorrhea-amenorrhea syndromes and functional sterility with increased prolactin concentration by means of bromocriptine (Parlodel-Sandoz)].
Tomala J; Dudkiewicz J; Blecharz AJ
Ginekol Pol; 1980 Mar; 51(3):255-8. PubMed ID: 6771191
[No Abstract] [Full Text] [Related]
54. Bromocriptine. Clinical experience in the induction of pregnancy in amenorrhea-galactorrhea syndrome.
Zárate A; Canales ES; Forsbach G; Fernández-Lazala R
Obstet Gynecol; 1978 Oct; 52(4):442-4. PubMed ID: 714326
[TBL] [Abstract][Full Text] [Related]
55. Galactorrhea-amenorrhea syndromes: etiology and treatment.
Spark RF; Pallotta J; Naftolin F; Clemens R
Ann Intern Med; 1976 May; 84(5):532-7. PubMed ID: 945033
[TBL] [Abstract][Full Text] [Related]
56. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
[TBL] [Abstract][Full Text] [Related]
57. Role of prolactin in human milk composition and serum lipids studied during suppression of galactorrhea with bromocriptine.
Kandan S; Gopalakrishnan V; Govindarajulu P; Indira R; Malathi T
Horm Res; 1983; 17(2):93-102. PubMed ID: 6682397
[TBL] [Abstract][Full Text] [Related]
58. Cyproheptadine in the management of the galactorrhea-amenorrhea syndrome.
Wortsman J; Soler NG; Hirschowitz J
Ann Intern Med; 1979 Jun; 90(6):923-5. PubMed ID: 571691
[TBL] [Abstract][Full Text] [Related]
59. [Results of bromocriptine treatment of women with functional amenorrhea-galactorrhea syndrome].
Baranowska B; Stopińska-Głuszek U; Jeske W
Endokrynol Pol; 1984; 35(4):219-29. PubMed ID: 6510365
[No Abstract] [Full Text] [Related]
60. [Treatment of the galactorrhea and amenorrhea syndrome associated with acromegaly using 2-bromine-alpha-ergocryptine].
Durić DS; Dordević PB; Mićić JV; Popović SS
Srp Arh Celok Lek; 1977 Feb; 105(2):179-89. PubMed ID: 562001
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
